These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18315420)

  • 1. Clinical evaluation of nanocrystalline hydroxyapatite paste in the treatment of human periodontal bony defects--a randomized controlled clinical trial: 6-month results.
    Kasaj A; Röhrig B; Zafiropoulos GG; Willershausen B
    J Periodontol; 2008 Mar; 79(3):394-400. PubMed ID: 18315420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial.
    Stein JM; Fickl S; Yekta SS; Hoischen U; Ocklenburg C; Smeets R
    J Periodontol; 2009 Nov; 80(11):1774-82. PubMed ID: 19905932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects.
    Park JS; Suh JJ; Choi SH; Moon IS; Cho KS; Kim CK; Chai JK
    J Periodontol; 2001 Jun; 72(6):730-40. PubMed ID: 11453234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study.
    Mengel R; Soffner M; Flores-de-Jacoby L
    J Periodontol; 2003 Jun; 74(6):899-908. PubMed ID: 12887004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
    Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
    J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
    Mengel R; Schreiber D; Flores-de-Jacoby L
    J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
    Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
    J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
    Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
    J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
    Batista EL; Novaes AB; Simonpietri JJ; Batista FC
    J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
    Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
    J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a bioactive glass alloplast in treating periodontal intrabony defects.
    Ong MM; Eber RM; Korsnes MI; MacNeil RL; Glickman GN; Shyr Y; Wang HL
    J Periodontol; 1998 Dec; 69(12):1346-54. PubMed ID: 9926764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing of intrabony peri-implantitis defects following application of a nanocrystalline hydroxyapatite (Ostim) or a bovine-derived xenograft (Bio-Oss) in combination with a collagen membrane (Bio-Gide). A case series.
    Schwarz F; Bieling K; Latz T; Nuesry E; Becker J
    J Clin Periodontol; 2006 Jul; 33(7):491-9. PubMed ID: 16820037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results.
    Leknes KN; Andersen KM; Bøe OE; Skavland RJ; Albandar JM
    J Periodontol; 2009 Feb; 80(2):219-27. PubMed ID: 19186961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of intrabony defects with bovine-derived xenograft alone and in combination with platelet-rich plasma: a randomized clinical trial.
    Hanna R; Trejo PM; Weltman RL
    J Periodontol; 2004 Dec; 75(12):1668-77. PubMed ID: 15732870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healing of intrabony defects following surgical treatment with or without an Er:YAG laser.
    Sculean A; Schwarz F; Berakdar M; Windisch P; Arweiler NB; Romanos GE
    J Clin Periodontol; 2004 Aug; 31(8):604-8. PubMed ID: 15257735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined periodontal regenerative technique in human intrabony defects by collagen membranes and anorganic bovine bone. A controlled clinical study.
    Paolantonio M
    J Periodontol; 2002 Feb; 73(2):158-66. PubMed ID: 11895280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirty-six month follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) bone replacement grafts in human infrabony defects. I. Clinical findings.
    Yukna RA; Krauser JT; Callan DP; Evans GH; Cruz R; Martin M
    J Periodontol; 2002 Jan; 73(1):123-8. PubMed ID: 11846193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.